National and Kapodistrian University of Athens
Μοριακή σταδιοποίηση στο κακοήθες μελάνωμα
Abstract
dc:descriptionA highly sensitive method for the detection of circulating melanocytes in patients with malignant melanoma has recently been described and confirmed. The application RT-PCR for the detection of Tyr-mRNA is based on the fact that the Tyr gene encoding for the key enzyme in melanin biosynthesis is actively expressed by melanocytic cells. Although the assay sensitivity can theoretically detect a single tumor cell among 10,000,000 normal cells, there are considerable variations in the stage related detection rates. The purpose of this study was to examine if there is a correlation between a positive assay result and known prognostic melanoma criteria, such as Clinical stage, Breslow thickness, Clark level, gender and histologic tumor type.We tested blood samples from 78 patients aged 30-82 years with malignant melanoma of all clinical stages (stage I: n=10, stage II: n=19, stage III: n=37, stage IV: n=12) for the expression of Tyr. Of the 78 patients whose total RNA was subjected to RT-nested_PCR for Tyr expression, 20 were found to be positive (25.6%). Positive results were also obtained in 1/10 (10%) of stage I patients, 3/19 (15.8%) of stage II patients, 9/37 (24.3%) of stage III patients and 7/12 (58.3%) of stage IV patients. This showed a clear stage correlation positivity and a remarkable correlation between the metastatic disease and the detection of circulating Tyr-mRNA positive cells (p:0.010). Furthermore, the probability of a positive result was found to be 5.33 times higher in metastatic patients than in patients with no distant métastasés. Our results are in agreement with other studies describing approximately 20%-60% positive PCR results in patients with distant métastasés. Barring the gender, no statistically significant correlation between other prognostic factors and positive RT-PCR exists. A remarkably higher percentage of female patients tested positive for Tyr compared to male patients. Overall, a positive RT-PCR was observed in 3 out of 32 (9.4%) male patients as compared to 17 out of 46 (37.9%) female patients (p:0.008). Contrary to previous studies that reported a higher percentage of tyrosinase positive males, our study shows the opposite, whereby females show a 3.9 fold increased probability of testing positive for Tyr than males. However, our analysis did not suggest the gender as an independent statistic variable, so the high Tyr positive rates of females cannot significantly be estimated of clinical value. In cases where the tumor thickness was greater than 4mm and the Clark level was equal to V, as in the cases of stage IV patients, we found a higher percentage of patients tested positive for Tyr.The clinical value of detection of circulating melanocytes has been investigated by several groups, with reported conflicting results. The limited number of cases in most of the previous studies and the different méthodologie approaches to sample preparation might account for the contrasting results on the reliability of the RT-PCR assay to test tumor progression in malignant melanoma patients.As a conclusion, our study demonstrates a significant correlation of metastatic disease with Tyr-PCR positive results. It is of great clinical value, since the assay can be routinely used as a follow up progression marker for early detection of hematogenous dissemination risk.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2004
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Mitropapas, Georgios
- Μητρόπαπας, Γεώργιος
Subjects
dc:subject × 14Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/23602